1. Hoang AD, Peterson M, Horde LB, Wright D, Rotshafter JC. Investigation of AUC/MIC ratio as a generic predictor of fluoroquinolone activity against Staphylococcus aureus using trovafloxacin, clinafloxacin, ciprofloxacin, sparfloxacin, levofloxacin and an in vitro model. In: Abstracts of the 98th General Meeting (Atlanta). Washington, DC: American Society for Microbiology, 1998:50.
2. Wright DH, Horde LB, Peterson ML, Hoang AD, Rotshafer JC. In vitro evaluation of pharmacodynamic outcome parameters for three fluoroquinolones against Streptococcus pneumoniae [abstract A86]. In: Abstracts of the 98th General Meeting (Atlanta). Washington, DC: American Society for Microbiology, 1998:53.
3. Zinner S, Gilbert D, Simmons K, Sarlak F. Moxifloxacin activity against S. pneumoniae in an in vitro dynamic model [abstract A26]. In: Abstracts of the 38th Interscience Conference on Antimicrobial Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.
4. Lister PD, Sanders CC. Pharmacodynamics of moxifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model [abstract A21]. In: Abstracts of the 38th Interscience Conference on Antimicrobial Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.
5. Activity of Moxifloxacin, Administered Once a Day, against
Streptococcus pneumoniae
in an In Vitro Pharmacodynamic Model of Infection